Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) announced that the company has developed a gel-like form of Oxycyte® that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier. The innovation is based on technologies in-licensed earlier this year from Virginia Commonwealth University.
This post is an original post by ScienceDaily: Skin Care News
